WINSTON-SALEM, N.C. – Thomas B. Clarkson, D.V.M., professor of comparative medicine at Wake Forest University School of Medicine, has received the 2009 American College of Laboratory Animal Medicine (ACLAM) Mentor Award. This award recognizes individuals who have contributed substantially to the membership of ACLAM by mentoring postdoctoral fellows, graduate students or junior level ACLAM diplomats during the course of their professional careers.
Clarkson arrived at Wake Forest Baptist in 1957 and is known internationally for his work in nonhuman primates as models for human disease research, including atherosclerosis research with the American Heart Association in the 1970s and 1980s, hormone replacement and women’s health. He has published more than 300 peer-reviewed articles and 86 book chapters.
“Clarkson was a ‘translational researcher’ long before the term was so popular,” said Janice D. Wagner, D.V.M., Ph.D., professor of comparative medicine. “His research has brought millions of dollars to Wake Forest University Health Sciences throughout the years.”
This award was presented Monday at the ACLAM Forum Awards Dinner at the Loews Ventana Canyon Hotel in Arizona.
###
Media Relations Contacts: Lisa Davanzo, ldavanzo@wfubmc.edu, (336) 716-6906; Bonnie Davis, bdavis@wfubmc.edu, (336) 716-4977; or Shannon Koontz, shkoontz@wfubmc.edu, (336) 716-4587.
Wake Forest University Baptist Medical Center (www.wfubmc.edu) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children’s Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university’s School of Medicine and Piedmont Triad Research Park. The system comprises 1,056 acute care, rehabilitation and long-term care beds and has been ranked as one of “America’s Best Hospitals” by U.S. News & World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America’s Top Doctors for the number of its doctors considered best by their peers. The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property.